Education
About Us
Working with TipRanks
Follow Us
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
Total Valuation
Krebs Biochemicals & Industries Ltd. has a market cap or net worth of ₹1.51B. The enterprise value is ₹3.78B.
Market Cap₹1.51B
Enterprise Value₹3.78B
Share Statistics
Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,560,587
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Krebs Biochemicals & Industries Ltd.’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is -18.66%.
Return on Equity (ROE)0.18
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-18.66%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee2.27M
Profits Per Employee-1.41M
Employee Count191
Asset Turnover0.26
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Krebs Biochemicals & Industries Ltd. is ―. Krebs Biochemicals & Industries Ltd.’s PEG ratio is -0.15.
PE Ratio―
PS Ratio3.37
PB Ratio-1.00
Price to Fair Value-1.00
Price to FCF-12.74
Price to Operating Cash Flow0.00
PEG Ratio-0.15
Income Statement
In the last 12 months, Krebs Biochemicals & Industries Ltd. had revenue of 433.12M and earned -269.39M in profits. Earnings per share was -12.50.
Revenue433.12M
Gross Profit377.56M
Operating Income-217.19M
Pretax Income-269.24M
Net Income-269.39M
EBITDA-143.21M
Earnings Per Share (EPS)-12.50
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Krebs Biochemicals & Industries Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.51
52-Week Price Change-28.44%
50-Day Moving Average68.67
200-Day Moving Average75.79
Relative Strength Index (RSI)52.05
Average Volume (3m)726.00
Important Dates
Krebs Biochemicals & Industries Ltd. upcoming earnings date is Feb 2, 2026, TBA (Confirmed).
Last Earnings DateNov 4, 2025
Next Earnings DateFeb 2, 2026
Ex-Dividend Date―
Financial Position
Krebs Biochemicals & Industries Ltd. as a current ratio of 0.10, with Debt / Equity ratio of 0.00%
Current Ratio0.10
Quick Ratio0.04
Debt to Market Cap1.45
Net Debt to EBITDA-14.81
Interest Coverage Ratio-3.67
Taxes
In the past 12 months, Krebs Biochemicals & Industries Ltd. has paid 153.00K in taxes.
Income Tax153.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Krebs Biochemicals & Industries Ltd. EV to EBITDA ratio is -24.99, with an EV/FCF ratio of -31.25.
EV to Sales8.26
EV to EBITDA-24.99
EV to Free Cash Flow-31.25
EV to Operating Cash Flow-45.36
Balance Sheet
Krebs Biochemicals & Industries Ltd. has ₹1.42M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹1.42M billion.
Cash & Marketable Securities₹1.42M
Total Debt₹0.00
Net Cash₹1.42M
Net Cash Per Share₹0.07
Tangible Book Value Per Share-₹68.91
Margins
Gross margin is 87.22%, with operating margin of -50.15%, and net profit margin of -62.20%.
Gross Margin87.22%
Operating Margin-50.15%
Pretax Margin-62.16%
Net Profit Margin-62.20%
EBITDA Margin-33.06%
EBIT Margin-48.51%
Analyst Forecast
The average price target for Krebs Biochemicals & Industries Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-46.31%
EPS Growth Forecast-26.28%